PANXEON Biomarker Improves Early Detection of Pancreatic Cancer
Published in Nature Medicine, a prospective study of 1,785 individuals across four countries demonstrates that the PANXEON exosome-based biomarker combined with carbohydrate antigen 19-9 achieves high sensitivity for detecting early-stage … Read More